In our study, patients with high lncRNA CASC9 expression acquired unfavorable clinical efficacy after chemotherapy, which might explain the fact that the sensitivity of tumor cells to chemotherapeutic drugs decreased due to the excessive expression of lncRNA CASC9, and finally, the chemotherapy was ineffective or even a failure. Here, CASC9 is linked to neoplasm.